Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Aus

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Urology|March 17, 2004
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionableBjørn Zackrisson, Gunnar Aus, Svante Bergdahl, et al.
Urology|July 22, 2008
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancerDavid Robinson, Gabriel Sandblom, Robert Johansson, et al.
The Journal of Urology|July 21, 2010
Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trialJohan Stranne, Gunnar Aus, Svante Bergdahl, et al.
European Urology|October 9, 2007
EAU guidelines on prostate cancerAxel Heidenreich, Gunnar Aus, Michel Bolla, et al.
BMC Urology|March 8, 2014
Effects of surgeon variability on oncologic and functional outcomes in a population-based settingSigrid Carlsson, Anders Berglund, Daniel Sjoberg, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic value of serum markers for prostate cancerUlf-Håkan Stenman, Per-Anders Abrahamsson, Gunnar Aus, et al.
European Urology|July 29, 2008
The European Association of Urology (EAU) guidelines methodology: a critical evaluationGunnar Aus, Christopher Chapple, Tomas Hanûs, et al.
The Lancet. Oncology|July 6, 2010
Mortality results from the Göteborg randomised population-based prostate-cancer screening trialJonas Hugosson, Sigrid Carlsson, Gunnar Aus, et al.
European Urology|May 28, 2003
Relative importance of sources of symptom-induced distress in urinary bladder cancer survivorsLars Henningsohn, Hans Wijkström, Kenneth Steven, et al.
BMC Medicine|July 10, 2008
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, SwedenAndrew J Vickers, Angel M Cronin, Gunnar Aus, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Urology|March 17, 2004
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionableBjørn Zackrisson, Gunnar Aus, Svante Bergdahl, et al.
Urology|July 22, 2008
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancerDavid Robinson, Gabriel Sandblom, Robert Johansson, et al.
The Journal of Urology|July 21, 2010
Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trialJohan Stranne, Gunnar Aus, Svante Bergdahl, et al.
European Urology|October 9, 2007
EAU guidelines on prostate cancerAxel Heidenreich, Gunnar Aus, Michel Bolla, et al.
BMC Urology|March 8, 2014
Effects of surgeon variability on oncologic and functional outcomes in a population-based settingSigrid Carlsson, Anders Berglund, Daniel Sjoberg, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic value of serum markers for prostate cancerUlf-Håkan Stenman, Per-Anders Abrahamsson, Gunnar Aus, et al.
European Urology|July 29, 2008
The European Association of Urology (EAU) guidelines methodology: a critical evaluationGunnar Aus, Christopher Chapple, Tomas Hanûs, et al.
The Lancet. Oncology|July 6, 2010
Mortality results from the Göteborg randomised population-based prostate-cancer screening trialJonas Hugosson, Sigrid Carlsson, Gunnar Aus, et al.
European Urology|May 28, 2003
Relative importance of sources of symptom-induced distress in urinary bladder cancer survivorsLars Henningsohn, Hans Wijkström, Kenneth Steven, et al.
BMC Medicine|July 10, 2008
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, SwedenAndrew J Vickers, Angel M Cronin, Gunnar Aus, et al.
Pageof 7